These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29082542)

  • 21. Sonographic abnormality of the substantia nigra in melanoma patients.
    Rumpf JJ; Weise D; Fricke C; Wetzig T; Simon JC; Classen J
    Mov Disord; 2013 Feb; 28(2):219-23. PubMed ID: 23114984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substantia Nigra Hyperechogenicity: Validation of Transcranial Sonography for Parkinson Disease Diagnosis in a Large Estonian Cohort.
    Toomsoo T; Liepelt-Scarfone I; Kerner R; Kadastik-Eerme L; Asser T; Rubanovits I; Berg D; Taba P
    J Ultrasound Med; 2016 Jan; 35(1):17-23. PubMed ID: 26589647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Usefulness of transcranial sonography in Parkinson's disease. A comparative study using 123I-FP-CIT SPECT].
    Hernández Vara J; Rubiera del Fueyo M; Lorenzo Bosquet C; Castell Conesa J; Molina Cateriano CA; Rodríguez FM
    Med Clin (Barc); 2008 Sep; 131(8):285-9. PubMed ID: 18803921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease.
    Weise D; Lorenz R; Schliesser M; Schirbel A; Reiners K; Classen J
    Mov Disord; 2009 Aug; 24(11):1669-75. PubMed ID: 19514075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcranial sonography of the substantia nigra: digital image analysis.
    Skoloudík D; Jelínková M; Blahuta J; Cermák P; Soukup T; Bártová P; Langová K; Herzig R
    AJNR Am J Neuroradiol; 2014 Dec; 35(12):2273-8. PubMed ID: 25059698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Life-long increase of substantia nigra hyperechogenicity in transcranial sonography.
    Hagenah J; König IR; Sperner J; Wessel L; Seidel G; Condefer K; Saunders-Pullman R; Klein C; Brüggemann N
    Neuroimage; 2010 May; 51(1):28-32. PubMed ID: 20152909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the substantia nigra by means of transcranial ultrasound imaging].
    Vivo-Orti MN; Tembl JI; Sastre-Bataller I; Vazquez-Costa JF; Sahuquillo P; Burguera JA
    Rev Neurol; 2013 Mar; 56(5):268-74. PubMed ID: 23440754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sonographic alteration of substantia nigra is related to parkinsonism-predominant course of X-linked dystonia-parkinsonism.
    Walter U; Rosales R; Rocco A; Westenberger A; Domingo A; Go CL; Brüggemann N; Klein C; Lee LV; Dressler D
    Parkinsonism Relat Disord; 2017 Apr; 37():43-49. PubMed ID: 28094105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome.
    Schmidauer C; Sojer M; Seppi K; Stockner H; Högl B; Biedermann B; Brandauer E; Peralta CM; Wenning GK; Poewe W
    Ann Neurol; 2005 Oct; 58(4):630-4. PubMed ID: 16037973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers.
    Ruprecht-Dörfler P; Klotz P; Becker G; Berg D
    Parkinsonism Relat Disord; 2007 Aug; 13(6):362-4. PubMed ID: 17055330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcranial sonography in patients with myotonic dystrophy type 1.
    Peric S; Pavlovic A; Ralic V; Dobricic V; Basta I; Lavrnic D; Rakocevic Stojanovic V
    Muscle Nerve; 2014 Aug; 50(2):278-82. PubMed ID: 24395217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury.
    Berg D; Roggendorf W; Schröder U; Klein R; Tatschner T; Benz P; Tucha O; Preier M; Lange KW; Reiners K; Gerlach M; Becker G
    Arch Neurol; 2002 Jun; 59(6):999-1005. PubMed ID: 12056937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcranial sonography findings in spinocerebellar ataxia type 3 (Machado-Joseph disease): a cross-sectional study.
    Pedroso JL; Bor-Seng-Shu E; Felício AC; Braga-Neto P; Teixeira MJ; Barsottini OG
    Neurosci Lett; 2011 Oct; 504(2):98-101. PubMed ID: 21939734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transcranial sonography for the diagnosis of Parkinson disease].
    Venegas F P; Miranda G G; Silva C MC
    Rev Med Chil; 2011 Jan; 139(1):54-9. PubMed ID: 21526317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.
    López Hernández N; García Escrivá A; Shalabi Benavent M
    Neurologia; 2015 Oct; 30(8):496-501. PubMed ID: 24839905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heightened Dopaminergic Response to Amphetamine at the D
    Boileau I; Payer D; Rusjan PM; Houle S; Tong J; McCluskey T; Wilson AA; Kish SJ
    Neuropsychopharmacology; 2016 Dec; 41(13):2994-3002. PubMed ID: 27353309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
    Walter U; Wittstock M; Benecke R; Dressler D
    J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy.
    Berg D; Jabs B; Merschdorf U; Beckmann H; Becker G
    Biol Psychiatry; 2001 Sep; 50(6):463-7. PubMed ID: 11566164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.